July 2018

340B Compliance: The Medicaid Exclusion File and Prevention of Duplicate Discounts

July 15, 2018

Viewpoints

Health care providers participating in the 340B program are prohibited from contributing to duplicate discounts, or the scenario that exists when a manufacturer provides a discounted 340B price and a rebate to Medicaid for the same drug.

Overview of Heart Failure Pharmacotherapy

July 14, 2018

Formulary Drug Review

Heart failure (HF) is estimated to cost Americans $30.7 billion each year, 68% of which is in direct costs and 32% in indirect ones, according to the American Heart Association (AHA).

Precision Pharmacotherapy: Ready for Prime Time?

July 11, 2018

Editor’s Note

In general, there is a lack of adequate evidence from well-designed, controlled clinical trials demonstrating that the use of pharmacogenomic data to individualize drug therapy is directly related to improvements in clinical outcome in nononcology therapeutic areas.